ADAM8
From Wikipedia, the free encyclopedia
A Disintegrin and metalloproteinase domain-containing protein 8 is an enzyme that in humans is encoded by the ADAM8 gene.[1][2]
This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The protein encoded by this gene may be involved in cell adhesion during neurodegeneration.[2]
[edit] See also
[edit] References
[edit] Further reading
- Yamamoto S, Higuchi Y, Yoshiyama K et al (1999). "ADAM family proteins in the immune system". Immunol. Today 20 (6): 278–84. doi:10.1016/S0167-5699(99)01464-4. PMID 10354553.
- Schlomann U, Rathke-Hartlieb S, Yamamoto S et al (2001). "Tumor necrosis factor alpha induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration". J. Neurosci. 20 (21): 7964–71. PMID 11050116.
- Amour A, Knight CG, English WR et al (2002). "The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs". FEBS Lett. 524 (1–3): 154–8. doi:10.1016/S0014-5793(02)03047-8. PMID 12135759.
- Strausberg RL, Feingold EA, Grouse LH et al (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=139241.
- Ishikawa N, Daigo Y, Yasui W et al (2005). "ADAM8 as a novel serological and histochemical marker for lung cancer". Clin. Cancer Res. 10 (24): 8363–70. doi:10.1158/1078-0432.CCR-04-1436. PMID 15623614.
- Kimura K, Wakamatsu A, Suzuki Y et al (2006). "Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes". Genome Res. 16 (1): 55–65. doi:10.1101/gr.4039406. PMC 1356129. PMID 16344560. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1356129.
- Foley SC, Mogas AK, Olivenstein R et al (2007). "Increased expression of ADAM33 and ADAM8 with disease progression in asthma". J. Allergy Clin. Immunol. 119 (4): 863–71. doi:10.1016/j.jaci.2006.12.665. PMID 17339047.
- Gómez-Gaviro M, Domínguez-Luis M, Canchado J et al (2007). "Expression and regulation of the metalloproteinase ADAM-8 during human neutrophil pathophysiological activation and its catalytic activity on L-selectin shedding". J. Immunol. 178 (12): 8053–63. PMID 17548643.
- Valkovskaya N, Kayed H, Felix K et al (2008). "ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer". J. Cell. Mol. Med. 11 (5): 1162–74. doi:10.1111/j.1582-4934.2007.00082.x. PMID 17979891.
[edit] External links
- The MEROPS online database for peptidases and their inhibitors: M12.208
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
|
|
|
| 1-50 |
|
|
| 51-100 |
|
|
| 101-150 |
|
|
| 151-200 |
|
|
| 201-250 |
|
|
| 251-300 |
|
|
| 301-350 |
|
|